Sign in

Trial result ·

Adjunctive gypenosides for acute optic neuritis: A prematurely terminated randomized, double-blind, placebo-controlled pilot trial in a cohort with frequent AQP4-IgG positivity.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This trial tested gypenosides in adults with optic neuritis. Each person had a first attack in the study eye within 28 days. All got the usual steroid drugs and were then split by chance into groups. One group took gypenosides, 180 mg a day for 10 days. The other group took a placebo, a dummy drug. The team planned to enroll 28 people but stopped after 10.

What they found

Of the 10 people, 6 got gypenosides and 4 got placebo. All but one person gave data after the start. 6 people tested positive for AQP4-IgG antibodies. The main test was a nerve layer's thickness in the eye at 6 months. This layer was 16.2 μm thicker with gypenosides, but this could be chance. Total macular volume showed no clear difference. Another layer, called mGCIPL, did differ between groups. But this was a side check, and eye function did not clearly improve.

What it means for patients

The trial did not meet its main goal. The authors say the mGCIPL result does not show the drug works. They say the trial gives useful data on how to run such studies. This may help plan future trials that group people by antibody status.

Why it is not certain yet

The trial ended early with only 10 people. The authors say it was far too small to show clear effects. It was run at a single center. The mGCIPL result came from an extra check, not the main question.

Source

Adjunctive gypenosides for acute optic neuritis: A prematurely terminated randomized, double-blind, placebo-controlled pilot trial in a cohort with frequent AQP4-IgG positivity.

PubMed · PMID 42398278

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Optic neuritis publications